Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|March 20, 2019
Primary Cilium in Cancer HallmarksLucilla Fabbri, Frédéric Bost, Nathalie M MazureBulletin Du Cancer|February 23, 2023
[Medulloblastoma: The latest major advances]Julie Contenti, Frédéric Bost, Nathalie M MazureCancer Prevention Research (Philadelphia, Pa.)|April 12, 2012
Prevention of mutagenesis: new potential mechanisms of metformin action in neoplastic cellsFrédéric Bost, Issam Ben-Sahra, Jean-François TantiAutophagy|June 19, 2010
The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cellsIssam Ben Sahra, Jean-François Tanti, Frédéric BostAnnales D'Endocrinologie|May 8, 2025
Prostate cancer and pollution: Dangerous connectionsSébastien Magnifico, Charlotte Hinault-Boyer, Frédéric Bost, et al.International Journal of Molecular Sciences|March 11, 2023
Critical Overview on Endocrine Disruptors in Diabetes MellitusCharlotte Hinault, Philippe Caroli-Bosc, Frédéric Bost, et al.Annales D'Endocrinologie|April 17, 2013
[New perspectives for metformin in cancer therapy]Camille Loubière, Béatrice Dirat, Jean-François Tanti, et al.Oncogene|July 12, 2005
A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cellsLeslie Caron, Frédéric Bost, Matthieu Prot, et al.Stem Cells (Dayton, Ohio)|January 16, 2007
Concise review: regulation of embryonic stem cell lineage commitment by mitogen-activated protein kinasesBernard Binétruy, Lynn Heasley, Frédéric Bost, et al.Cancer Letters|January 28, 2014
Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemiaCélia Rosilio, Issam Ben-Sahra, Frédéric Bost, et al.Pageof 6